General Info
Brian Gill is an experienced Senior Communications and Investor Relations Consultant with previous roles at Gamida Cell, TYME Technologies Inc., and Celgene. His investment focus areas include biotech and medical innovation. With experience in global corporate communications, he brings expertise in fostering investor relations. Brian holds a Bachelor’s of Science with a major in Biology and a minor in Chemistry from West Chester University of Pennsylvania. He also holds Series 7 & Series 63 licenses from FINRA. Brian has been involved in the Value Of Medical Innovation Initiative project.,
Location:
Country: Barbados
Industries:
Investment Regions:
Investment Stages: pre-seed, seed
angel-individual
Want to start building warm intros with this investor?
🤖 AI Activity Report
Status: not-found
AI Reasoning: Extensive search of public sources (LinkedIn and related profiles) shows Brian Gill is a communications and investor relations consultant with roles at Gamida Cell, TYME Technologies and Celgene, but no public record of investments or startup investments was found. No specific startup investment name or date of investment could be identified to assess recency, so defaulting to not-found.
Angel activity thresholds:
Low Activity – Only known angel investments more than 12 months ago.
Active – Known angel investments between the last 12 and 6 months.
Very Active – Known angel investments in the last 6 months.
Investor Contact
Team Members
Name
Role
Email
LinkedIn
…
…
…
…
…
Investment Regions Map
loading map…
Similar Investors
Other similar investors:
Latest on X (Twitter)
Access all contact details of Brian Gill
Gain instant access to partner names, verified emails, LinkedIn profiles, and more—all in one place. Dive into their portfolio founders and their LinkedIn information, so you can quickly start your outreach and look for warm intros.
Add custom tags to your investor cards. Label them by investment stage, industry focus, interest level, or any other criteria you want to stay organized.
Trusted by Founders like You
Find your matching investors using AI